Pfizer Stock Surges on Trump’s Drug Price Deal & $7B Obesity Gamble – Is This the Comeback Investors Hoped For?
Technical Analysis – Levels to Watch From a technical perspective, Pfizer’s stock has been basing in the low-to-mid $20s and has yet to break out of its longer-term downtrend. The 52-week range is roughly $20.92 to $30.43 ts2.tech, and the late-September rally stalled out near the upper-$20s – a zone that now acts as an overhead resistance (around $26–$27). Notably, PFE is trading below its 200-day moving average (~$27), indicating lingering bearish momentum trefis.com. On the upside, a decisive push above the $27–$28 level (and the 200-day MA) would be a bullish signal that the stock’s trend is turning. In